EGFr is overexpressed in the majority of HNSCC [4] and activation of the receptor leads to phosphorylation of the tyrosine kinase domains on the intracellular part of the receptor, activating downstream cascades which result in altered gene activation and modulation of the cell products. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.